Overview

Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome

Status:
Terminated
Trial end date:
2019-03-27
Target enrollment:
Participant gender:
Summary
This is a non-randomized, un-blinded feasibility study project comparing the Length of Stay (LOS) of Neonatal Intensive Care Unit (NICU) infants diagnosed with Neonatal Abstinence Syndrome (NAS) treated with methadone with historical data and a comparison group of NICU NAS infants treated with a different narcotic agent.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins All Children's Hospital
Collaborator:
Florida Department of Health
Treatments:
Methadone
Morphine